You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 98 No. 3, March 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Experimental Herpetic Interstitial Keratitis With Medroxyprogesterone

Jonathan H. Lass, MD; Michael B. Berman, PhD; Robert C. Campbell, MD; Deborah Pavan-Langston, MD; Janet Gage

Arch Ophthalmol. 1980;98(3):520-527.


Abstract

• A model of herpes simplex interstitial keratitis was developed in rabbits sensitized with live herpes simplex virus (HSV) type 2 and challenged intrastromally with live virus. This model was used to evaluate the effects of subconjunctival medroxyprogesterone acetate on the course of the disease and on collagenase levels in the treated corneas. Whether treated prophylactically or therapeutically, the medroxyprogesterone-treated groups had substantially less stromal infiltration and neovascularization than the controls. The clinical effects corresponded with a marked reduction in the polymorphonuclear leukocyte infiltrate histologically, and the suppression of latent and active collagenase activity in the treated corneas cultured in vitro. However, epithelial disease was exacerbated in prophylactically treated animals. Medroxyprogesterone appears to be useful in the treatment of herpetic interstitial keratitis as an anti-inflammatory agent as well as an inhibitor of collagenase production but, like the corticosteroids, it can exacerbate epithelial disease.



Author Affiliations

From the Department of Cornea Research, Eye Research Institute of Retina Foundation (Drs Lass, Berman, Campbell, Pavan-Langston, and Ms Gage) and the Department of Ophthalmology, Harvard Medical School (Drs Lass, Berman, Campbell, and Pavan-Langston), Boston. Dr Lass is now with University Hospitals, Cleveland.


Footnotes

Accepted for publication June 4, 1979.

Reprint requests to Division of Ophthalmology, University Hospitals, 2065 Adelbert Rd, Cleveland, OH 44106 (Dr Lass).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Experimental Interstitial Keratitis Induced by Onchocerca volvulus Antigens
Gallin et al.
Arch Ophthalmol 1988;106:1447-1452.
ABSTRACT  

Effects of Prednisolone and Medroxyprogesterone on Corneal Wound Healing, Ulceration, and Neovascularization
Phillips et al.
Arch Ophthalmol 1983;101:640-643.
ABSTRACT  

Medroxyprogesterone on Corneal Ulceration Its Effects After Alkali Burns on Rabbits
Lass et al.
Arch Ophthalmol 1981;99:673-676.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.